MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY by Emanuele Angelucci, Silvana Anna Maria Urru, Federica Pilo, Alberto Piperno

Subjects: Get full text

LONGITUDINAL STUDY ON LIVER FUNCTIONS IN PATIENTS WITH THALASSEMIA MAJOR BEFORE AND AFTER DEFERASIROX (DFX) THERAPY by Ashraf Tawfik Soliman, Mohamed Yassin, Fawzia AlYafei, Lolwa Al-Naimi, Noora Almarri, Aml Sabt, Vincenzo De Sanctis

Subjects: “…Thalassemia, liver enzymes, Insulin-like growth factor-I (IGF-I), chelation therapy…”
Get full text

JADENU® SUBSTITUTING EXJADE® IN IRON OVERLOADED Β- THALASSEMIA MAJOR (BTM) PATIENTS: A PRELIMINARY REPORT OF THE EFFECTS ON THE TOLERABILITY, SERUM FERRITIN LEVEL, LIVER IRON CONCE... by Vincenzo De Sanctis

Subjects: Get full text

DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA by Ali Taher

Subjects: “…iron overload, iron chelation therapy, transfusion dependent thalassemia, non-transfusion dependent thalassemia, serum ferritin, liver iron concentration, deferasirox…”
Get full text